BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-20 15:38 | English | 12.8 KB | |||
| 2025-10-02 09:05 | English | 5.7 KB | |||
| 2025-09-03 09:30 |
BRAIN Biotech AG appoints Johan Jansen-Storbacka as Executive Vice President of…
|
English | 14.1 KB | ||
| 2025-08-28 07:30 |
BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalys…
|
English | 20.4 KB | ||
| 2025-08-28 00:00 |
Q3 statement / Q3 financial report 2024/2025
|
English | 274.7 KB | ||
| 2025-08-25 07:30 |
Corbion and BRAIN Biotech team to shape the future of innovation in nature-base…
|
English | 11.5 KB | ||
| 2025-07-23 08:30 |
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
|
English | 13.4 KB | ||
| 2025-06-23 08:05 |
Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billio…
|
English | 22.4 KB | ||
| 2025-05-28 07:30 |
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
|
English | 20.0 KB | ||
| 2025-05-28 00:00 |
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2024 bis zum 31.03…
|
German | 99.2 KB | ||
| 2025-05-28 00:00 |
Half-yearly financial report 2024/2025
|
English | 364.5 KB | ||
| 2025-05-21 10:00 |
BRAIN Biotech announces buy-out of minorities, new continental European product…
|
English | 16.2 KB | ||
| 2025-05-19 11:23 | English | 4.1 KB | |||
| 2025-05-19 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
|
German | 5.8 KB | ||
| 2025-04-30 17:54 |
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
|
English | 6.0 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
